Aurinia Pharmaceuticals
AUPH
14.70
-0.19
-1.28%
Aurinia Pharmaceuticals
US · AUPH
#2749 by market cap
Listed 1970
14.70
-0.19
-1.28%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
Quant vs Street three independent views, side by side
StockVane factor grade
A-
Momentum strategy signal
Sell
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
✦ Quant Analyst Revision Trend how this is computed
Mixed
1
■ Upgrades■ Downgrades
- 1 upgrade vs 0 downgrades among tracked analyst rating changes.
- Most recent: Bloom Burton moved from Hold to Buy on 2026-08-20.
Analyst consensus 3 analysts
Buy
Avg price target 19.00 +29.3%
Price target rangecurrent 14.70
Low18.00
Avg19.00
High21.00
Buy 67%
Hold 33%
Sell 0%
Recent ratings (20)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-02 | Bloom Burton | -- | Buy | 21.00 |
| 2026-10-30 | RBC Capital | -- | Hold | 18.00 |
| 2026-10-21 | TD Cowen | -- | Buy | 18.00 |
| 2026-08-20 | Bloom Burton | -- | Buy | 21.00 |
| 2026-08-19 | TD Cowen | -- | Buy | 17.00 |
| 2026-08-06 | TD Cowen | -- | Buy | 17.00 |
| 2026-07-20 | TD Cowen | -- | Buy | 17.00 |
| 2026-07-06 | TD Cowen | -- | Buy | 17.00 |
| 2026-05-07 | TD Cowen | -- | Buy | 17.00 |
| 2026-03-31 | Bloom Burton | -- | Hold | 15.00 |
| 2026-03-30 | TD Cowen | -- | Buy | 17.00 |
| 2026-02-27 | Bloom Burton | -- | Hold | 15.00 |
| 2026-02-27 | H.C. Wainwright | -- | Buy | 17.00 |
| 2026-02-27 | RBC Capital | -- | Hold | 15.00 |
| 2026-02-26 | TD Cowen | -- | Buy | 17.00 |
| 2025-12-03 | Leerink Partners | -- | Hold | 16.00 |
| 2025-11-07 | Jefferies | -- | Buy | 21.00 |
| 2025-11-05 | H.C. Wainwright | -- | Buy | 17.00 |
| 2025-11-04 | TD Cowen | -- | Buy | 17.00 |
| 2025-11-04 | RBC Capital | -- | Hold | 15.00 |
Price target trend monthly average, last 3 years
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-08-20 | Bloom Burton | Hold → Buy | 21.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2025/Q4 | 2026-02-26 | -- | ±17.50% | -3.19% (in line) |
| 2025/Q3 | 2025-11-04 | -- | ±12.70% | +8.35% (in line) |
| 2025/Q2 | 2025-07-31 | -- | ±13.44% | +2.15% (in line) |
| 2025/Q1 | 2025-05-12 | -- | ±15.99% | +1.50% (in line) |
| 2024/Q4 | 2025-02-27 | -- | ±18.36% | -5.03% (in line) |
| 2024/Q3 | 2024-11-07 | -- | ±14.32% | +10.90% (in line) |
| 2024/Q2 | 2024-08-01 | -- | ±16.22% | -4.59% (in line) |
| 2024/Q1 | 2024-05-02 | -- | ±18.21% | -0.58% (in line) |
| 2023/Q4 | 2024-02-15 | -- | ±14.64% | -24.47% (beat) |
| 2023/Q3 | 2023-11-02 | -- | ±23.14% | +10.52% (in line) |
| 2023/Q2 | 2023-08-03 | -- | ±25.02% | +4.24% (in line) |
| 2023/Q1 | 2023-05-04 | -- | ±20.50% | -2.99% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 20:02:19 · For reference only, not investment advice and not tailored to your situation.
Aurinia Pharmaceuticals discussion 0 comments